Stay updated on GB002 Open-Label Extension in PAH Clinical Trial
Sign up to get notified when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.
Latest updates to the GB002 Open-Label Extension in PAH Clinical Trial page
- Check3 days agoChange DetectedThe screenshots show the same Study Details page for NCT04816604 with no additions or deletions to core sections; minor visual tweaks may be present but do not alter the study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check11 days agoChange DetectedNo significant changes to the study record were observed. Updates seem to be routine informational additions, such as new publications, and minor formatting changes.SummaryDifference0.1%
- Check18 days agoChange DetectedThe study locations have been updated to 28 sites, with Oregon Health & Science University (Portland, OR) and Lundquist Institute at Harbor-UCLA (Torrance, CA) removed from the list.SummaryDifference0.4%
- Check25 days agoChange DetectedPublications section description updated to reflect that publications are automatically filled in from PubMed, using revised wording. Page revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%
- Check32 days agoChange DetectedRemoval of the general operating status notice about government funding and NIH Clinical Center. This change does not affect study details or the information presented about the trial; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check39 days agoChange DetectedThe study locations list now shows 30 sites, with Stanford, CA removed, changing the total number of locations from 31 to 30.SummaryDifference0.4%
Stay in the know with updates to GB002 Open-Label Extension in PAH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB002 Open-Label Extension in PAH Clinical Trial page.